ÁÖ¹®°æ

  • Áø·á°ú

    ¼ÒÈ­±â³»°ú

  • Àü¹®Áø·áºÐ¾ß

    À§Àå°ü Áúȯ, À§Àå°ü ÃâÇ÷, À§Àå°ü »óÇÇÇÏ Á¾¾ç, À§Àå°ü ¾ç¼ºÁ¾¾ç, À§Àå°ü ¾ç¼ºÁúȯ, »óºÎÀ§Àå°ü, Á¶±âÀ§¾Ï, À§Á¡¸·ÇÏÁ¾¾ç, À§¿ëÁ¾, À§¿°, ±â´É¼º À§ÀåÁúȯ, À§Àå°üÀ̹°»ïÅ´, ½Ê..

  • ´ã´çŬ¸®´Ð

    À§¾Ï Ŭ¸®´Ð , Ä¡·á´ëÀå³»½Ã°æŬ¸®´Ð

  • °ü·Ã¼¾ÅÍ

    ¼ÒÈ­±â³»½Ã°æ¼¾ÅÍ , ´ëÀå¾Ï ¼¾ÅÍ

ÁÖ¹®°æ
¼¼ºÎÀü°ø
½Äµµ Áúȯ, À§Àå°üÁúȯ
Áúȯ±º
±â´É¼º À§Àå Áúȯ, À§ ¼±Á¾, À§¾Ï, ´ëÀå ¿ëÁ¾, ¼ÒÈ­¼º±Ë¾ç, À§Àå°ü ÃâÇ÷
Áõ»ó±º
¼ÒÈ­ ºÒ·®, º¯ºñ, °ú¹Î¼º Àå ÁõÈıº, À§Àå°ü Á¾¾ç, ¼Ó¾²¸², ¸íÄ¡ ÅëÁõ, Èæ»öº¯, ÅäÇ÷

ÁÖ¹®°æ ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
¼ÒÈ­±â³»°ú
¿ÀÀü
¿ÀÈÄ
-
¿ÀÀü
- - À§Àå°ü Áúȯ, À§Àå°ü ÃâÇ÷, À§Àå°ü »óÇÇÇÏ Á¾¾ç, À§Àå°ü ¾ç¼ºÁ¾¾ç, À§Àå°ü ¾ç¼ºÁúȯ, »óºÎÀ§Àå°ü, Á¶±âÀ§¾Ï, À§Á¡¸·ÇÏÁ¾¾ç, À§¿ëÁ¾, À§¿°, ±â´É¼º À§ÀåÁúȯ, À§Àå°üÀ̹°»ïÅ´, ½ÊÀÌÁöÀå¿ëÁ¾, ½ÊÀÌÁöÀå±Ë¾ç, Ä¡·á³»½Ã°æ, ¼ÒÈ­±â¾Ï...

ÁÖ¹®°æ ±³¼öÀÇ »ó¼¼Á¤º¸

ÇзÂ

more
  • 1993 .03 .01 ~  1999 .02 .28 :  °í·Á´ëÇб³ ÀÇÇаú
  • 2005 .03 .01 ~  2007 .02 .28 :  °í·Á´ëÇб³ ÀÇÇÐ ¼®»ç
  • 2007 .09 .01 ~  2010 .02 .28 :  °í·Á´ëÇб³ ÀÇÇÐ ¹Ú»ç

°æ·Â

more
  • 2007 .03  ~  2009 .02  :  °í·Á´ëÇб³ ±¸·Îº´¿ø ¼ÒÈ­±â³»°ú ÀÓ»ó°­»ç
  • 2009 .03  ~  2010 .02  :  °í·Á´ëÇб³ ±¸·Îº´¿ø ¼ÒÈ­±â³»°ú ÀÓ»óÁ¶±³¼ö
  • 2013 .03  ~  2015 .02  :  °í·Á´ëÇб³ ±¸·Îº´¿ø ¼ÒÈ­±â³»°ú ÀÓ»óÁ¶±³¼ö/ÀÓ»óºÎ±³¼ö
  • 2015 .03  ~  2018 .08  :  °í·Á´ëÇб³ ±¸·Îº´¿ø ¼ÒÈ­±â³»°ú ºÎ±³¼ö
  • 2018 .09  ~   :  °í·Á´ëÇб³ ±¸·Îº´¿ø ¼ÒÈ­±â³»°ú ±³¼ö

¼ö»ó³»¿ª

more
  • 2015 .12  :  ´ëÇÑ»óºÎÀ§Àå°ü-Ç︮ÄÚ¹ÚÅÍÇÐȸ ¿ì¼öÆ÷½ºÅÍ»ó
  • 2015 .11  ~  2017 .10  :  Çѱ¹¿¬±¸Àç´Ü Çѱ¹Çü SGER ¼±Á¤
  • 2019 .07  ~  2021 .06  :  ´ëÇÑ»óºÎÀ§Àå°ü-Ç︮ÄÚ¹ÚÅÍÇÐȸ ¿¬±¸»ó
  • 2021 .03  :  ´ëÇÑ»óºÎÀ§Àå°ü-Ç︮ÄÚ¹ÚÅÍÇÐȸ ¿ì¼ö±¸¿¬»ó

ÇÐȸȰµ¿

more
  • 2017 .12  ~  2018 .11  :  ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎÃѹ«
  • 2018 .12  ~  2019 .11  :  ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ À繫ÀÌ»ç
  • 2021 .03  ~  2023 .02  :  ´ëÇÑ»óºÎÀ§Àå°ü-Ç︮ÄÚ¹ÚÅÍÇÐȸ ÇмúÀÌ»ç

³í¹®

more
  • [SCIE] (Ten-year trends of utilizing palliative care and palliative procedures in patients with gastric Cancer in the United States from 2009 to 2018 - a nationwide database study)
  • [SCI] (Prediction model for curative endoscopic submucosal dissection of undifferentiated-type early gastric cancer)
  • [SCIE] (Clinical Guidelines for Drug-Related Peptic Ulcer, 2020 Revised Edition)
  • [SCIE] (Characteristics of proximal early gastric cancer differentiating distal early gastric cancer)
  • [SCIE] (Proton pump inhibitor: The dual role in gastric cancer)
  • [SCIE] (Inhibition of STAT3 in gastric cancer: role of pantoprazole as SHP-1 inducer)
  • [SCIE] (Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells)
  • [SCIE] (Additional Benefits of Routine Drugs on Gastrointestinal Cancer: Statins, Metformin, and Proton Pump Inhibitors)
  • [SCIE] (Endoscopic Approach for Major Complications of Bariatric Surgery)
  • [SCI] (Impact of homeobox genes in gastrointestinal cancer)
  • [SCI] (The roles of HOXB7 in promoting migration, invasion and anti-apoptosis in gastric cancer)
  • [SCIE] (Recent updates of precision therapy for gastric cancer: Towards optimal tailored management)
  • [SCI] (Epigenetic regulation and anti-tumorigenic effects of SH2-containing protein tyrosine phosphatase 1 (SHP1) in human gastric cancer cells)
  • [SCI] (Endoscopic versus surgical resection of GI stromal tumors in the upper GI tract)
  • [SCIE] (Antitumorigenic effect of plumbagin by induction of SH2-containing protein tyrosine phosphatase 1 in human gastric cancer cells)
  • [SCIE] (Prevalence and endoscopic features of eosinophilic esophagitis in patients with esophageal or upper gastrointestinal symptoms.)
  • [SCI] (Differences in the prevalence of colorectal polyps in patients undergoing endoscopic removal of gastric adenoma or early gastric cancer and in healthy individuals.)

Àú¼­

more
  • Advances in Carcinogenesis Research
  • À§¾Ï°ú À§Àå°ü Áúȯ
  • ¼ÒÈ­±â³»½Ã°æ Ä¡·á ¾ÆƲ¶ó½º
  • ºñ¸¸°ú ´ë»çÁúȯÀÇ ³»½Ã°æÄ¡·á

ÃÖÁ¾¼öÁ¤ÀÏ : 2023.05.08